Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients

Pain

Volumn 109, Issue 1-2, 2004, Pages 132-142

  Dougherty, Patrick M ^a   Cata, Juan P ^a   Cordella, Joseph V ^a   Burton, Allen ^a   Weng, Han Rong ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; Chemotherapy; Neuropathy; Psychophysics

Indexed keywords

AMITRIPTYLINE; CELECOXIB; GABAPENTIN; NAPROXEN; NORTRIPTYLINE; PACLITAXEL DERIVATIVE; PARACETAMOL;

ADULT; AGED; ARTICLE; BURNING SENSATION; CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLABROUS SKIN; HAND; HEAT TOLERANCE; HUMAN; LIMB; MALE; MYELINATED NERVE; NEUROPATHIC PAIN; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSORY DYSFUNCTION; TOUCH;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NERVE FIBERS, MYELINATED; NOCICEPTORS; PACLITAXEL; PAIN; PAIN THRESHOLD; PSYCHOMOTOR PERFORMANCE; SENSATION DISORDERS; SENSORY THRESHOLDS; SKIN; TIME FACTORS;

EID: 1842735565     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2004.01.021     Document Type: Article

References (75)

1. Alberts D.S., Noel J.K. Cisplatin-associated neurotoxicity: can it be prevented? Anticancer Drugs. 6:1995;369-383.
2. Aley K.O., Reichling D.B., Levine J.D. Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience. 73:1996;259-265.
3. Archer D.R., Dahlin L.B., McLean W.G. Changes in slow axonal transport of tubulin induced by local application of colchicine to rabbit vagus nerve. Acta Physiol Scand. 150:1994;57-65.
4. Beise R.D., Carstens E., Kohlloffel L.U.E. Psychophysical study of stinging pain evoked by brief freezing of superficial skin and ensuing short-lasting changes in sensations of cool and cold pain. Pain. 74:1998;275-286.
5. Berger T., Malayeri R., Doppelbauer A., Krajnik G., Huber H., Auff E., Pirker R. Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy. Eur J Cancer. 33:1997;1393-1399.
6. Bradley W.G., Lassman L.P., Pearce G.W., Walton J.N. The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J Neurol Sci. 10:1970;107-131.
7. Casey E.B., Jellife A.M., Le Quesne P.M., Millet Y.L. Vincristine neuropathy. Clinical and electrophysiological observations. Brain. 96:1973;69-86.
8. Cavaletti G., Bogliun G., Marzorati L., Zincone A., Marzola M., Colombo N., Tredici G. Peripheral neurotoxicity of taxol in patients previously treated with cisplatin. Cancer. 75:1995;1141-1150.
9. Cavaletti G., Tredici G., Braga M., Tazzari S. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp Neurol. 133:1995;64-72.
10. Cavaletti G., Cavaletti E., Oggioni N., Sottani C., Minoia C., D'Incalci M., Zucchetti M., Marmiroli P., Tredici G. Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration. Neurotoxicology. 21:2000;389-394.
11. Chan A.W., MacFarlane I.A., Bowsher D., Campbell J.A. Weighted needle pinprick sensory thresholds: a simple test of sensory function in diabetic peripheral neuropathy. J Neurol Neurosurg Psychiatry. 55:1992;56-59.
12. Chaudhry V., Rowinsky E.K., Sartorius S.E., Donehower R.C., Cornblath D.R. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol. 35:1994;304-311.
13. Cho E.S., Lowndes H.E., Goldstein B.D. Neurotoxicology of vincristine in the cat. Morphological study. Arch Toxicol. 52:1983;83-90.
14. Cliffer K.D., Siuciak J.A., Carson S.R., Radley H.E., Park J.S., Lewis D.R., Zlotchenko E., Nguyen T., Garcia K., Tonra J.R., Stambler N., Cedarbaum J.M., Bodine S.C., Lindsay R.M., DiStefano P.S. Physiological characterization of taxol-induced large fiber sensory neuropathy in the rat. Ann Neurol. 43:1998;46-55.
15. Contreras P.C., Vaught J.L., Gruner J.A., Brosnan C., Steffler C., Arezzo J.C., Lewis M.E., Kessler J.A., Apfel S.C. Insulin-like growth factor-I prevents development of a vincristine neuropathy in mice. Brain Res. 774:1997;20-26.
16. Dahlstrom A. Effect of colchicine on transport of amine storage granules in sympathetic nerve of rat. Eur J Pharmacol. 5:1968;111-113.
17. Fazio R., Quattrini A., Bolognesi A., Bordogna G., Villa E., Previtali S., Canal N., Nemmi R. Docetaxel neuropathy: a distal axonopathy. Acta Neuropath (Berlin). 98:1999;651-653.
18. Forman A. Peripheral neuropathy in cancer patients: clinical types, etiology and presentation. Oncology. 4:1990;85-89.
19. Forsyth P.A., Balmaceda C., Peterson K., Seidman A.D., Brasher P., DeAngelis L.M. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neurooncol. 35:1997;47-53.
20. Fruhstorfer H. Thermal sensibility changes during ischemic nerve block. Pain. 20:1984;355-361.
21. Fruhstorfer H., Zenz M., Nolte H., Hensel H. Dissociated loss of cold and warm sensibility during regional anaesthesia. Pflugers Arch Physiol. 349:1974;73-82.
22. Fuchs P.N., Campbell J.N., Meyer R.A. Secondary hyperalgesia persists in capsaicin desensitized skin. Pain. 84:2000;141-149.
23. Gao W.-Q., Dybal N., Shinsky N., Murnane A., Schmelzer C., Siegel M., Keller G., Hefti F., Phillips H.S., Winslow J.W. Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann Neurol. 38:1995;30-37.
24. Garber K. Cancer research. Taking garbage in, tossing cancer out? Science. 295:2002;612-613.
25. van Gerven J.M.A., Moll J.W.B., van den Bent M.J., Bontenbal M., van der Burg M.E.L., Verweij J., Vecht C.J. Paclitaxel (taxol) induces cumulative mild neurotoxicity. Eur J Cancer. 30A:1994;1074-1077.
26. Harrison J.L.K., Davis K.D. Cold-evoked pain varies with skin type and cooling rate: a psychophysical study in humans. Pain. 83:1999;123-135.
27. Hayakawa K., Itoh T., Niwa H., Mutoh T., Sobue G. NGF prevention of neurotoxicity induced by cisplatin, vincristine and taxol depends on toxicity of each drug and NGF treatment schedule: in vitro study of adult rat sympathetic ganglion explants. Brain Res. 794:1998;313-319.
28. Hensel H., Boman K.K.A. Afferent impulses in cutaneous sensory nerves in human subjects. J Neurophysiol. 23:1960;564-578.
29. Holland J.F., Scharlau C., Gailani S., Krant M.J., Olson K.B., Horton J., Shnider B.I., Lynch J.J., Owens A., Carbone P.P., Colsky J., Grob D., Miller S.P., Hall T.C. Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res. 33:1973;1258-1264.
30. Horie H., Takenaka T., Ito S., Kim S.U. Taxol counteracts colchicine blockade of axonal transport in neurites of cultured dorsal root ganglion cells. Brain Res. 420:1987;144-146.
31. Iñiguez C., Larrodé P., Mayordomo J.I., González P., Adelantado S., Yubero A., Trés A., Morales F. Reversible peripheral neuropathy induced by a single administration of high-dose paclitaxel. Neurology. 51:1998;868-870.
32. Jordan M.A., Thrower D., Wilson L. Mechanism of inhibition of cell proliferation by vinca alkaloids. Cancer Res. 51:1991;2212-2222.
33. Kaplan R.S., Wiernik P.H. Neurotoxicity of antineoplastic drugs. Semin Oncol. 9:1982;103-130.
34. Kellie S.J., Barbaric D., Koopmans P., Earl J., Carr D.J., de Graaf S.S.N. Cerebrospinal fluid concentrations of vincristine after bolus intravenous dosing. Cancer. 94:2002;1815-1820.
35. Kingery W.S., Guo T.-Z., Poree L.R., Maze M. Colchicine treatment of the sciatic nerve reduces neurogenic extravasation, but does not affect nociceptive thresholds or collateral sprounting in neuropathic rats. Pain. 74:1998;11-20.
36. Knibestol M. Stimulus-response functions of rapidly adapting mechanoreceptors in the human glabrous skin area. J Physiol. 232:1973;427-452.
37. Knibestol M. Stimulus-response functions of slowly adapting mechanoreceptors in the human glabrous skin area. J Physiol. 245:1975;63-80.
38. Konietzny F., Hensel H. Warm fiber activity in human skin nerves. Pflugers Arch Physiol. 359:1975;265-267.
39. Krarup-Hansen A., Fugleholm K., Helweg-Larsen S., Hauge E.N., Schmalbruch H., Trojaborg W., Krarup C. Examination of distal involvement in cisplatin-induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function. Brain. 116:1993;1017-1041.
40. LaMotte R.H., Campbell J.N. Comparison of responses of warm and nociceptive C-fiber afferents in monkey with human judgments of thermal pain. J Neurophysiol. 41:1978;509-528.
41. Lenz F.A., Dougherty P.M. Neurons in the human thalamic principal somatosensory nucleus (ventralis caudalis Vc) respond to innocuous cool and mechanical stimuli. J Neurophysiol. 79:1998;2227-2230.
42. Lenz F.A., Gracely R.H., Hope E.J., Baker F.H., Rowland L.H., Dougherty P.M., Richardson R.T. The sensation of angina can be evoked by stimulation of the human thalamus. Pain. 59:1994;119-125.
43. Lipton R.B., Apfel S.C., Dutcher J.P., Rosenberg R., Kaplan J., Berger A., Einzig A.I., Wiernik P., Schaumburg H.H. Taxol produces a predominantly sensory neuropathy. Neurology. 39:1989;368-373.
44. Lobert S., Vulevic B., Correia J.J. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine and vinorelbine. Biochemistry. 35:1996;6806-6814.
45. MacFarlane B.V., Wright A., Benson H.A.E. Reversible blockade of retrograde axonal transport in the rat sciatic nerve by vincristine. J Pharm Pharmacol. 49:1997;97-101.
46. Mellgren S.I. Alpha-interferon therapy and peripheral neuropathy. Pediatr Hematol Oncol. 16:1999;500.
47. Melzack R., Wall P.D. Pain mechanisms: a new theory. Science. 150:1965;971-979.
48. Mizobuchi K., Kuwara S., Toma S., Nakajima Y., Ogawara K., Hattori T. Properties of human skin mechanoreceptors in peripheral neuropathy. Clin Neurophysiol. 113:2002;310-315.
49. Morin C., Bushnell M.C. Temporal and qualitative properties of cold pain and heat pain: a psychophysical study. Pain. 74:1998;67-73.
50. Ogawa T., Mimura Y., Isowa K., Kato H., Mitsuishi M., Toyoshi T., Kuwayama N., Morimoto H., Murakoshi T., Nakayama T. An antimicrotubule agent, TZT-1027, does not induce neuropathologic alterations which are detected after administration of vincristine or paclitaxel in animal models. Toxicol Lett. 121:2001;97-106.
51. Pal P.K. Clinical and electrophysiological studies in vincristine induced neuropathy. Electromyogr Clin Neurophysiol. 39:1999;323-330.
52. Polomano R.C., Mannes A.J., Clark U.S., Bennett G.J. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain. 94:2001;293-304.
53. Postma T.J., Benard B.A., Huijgens P.C., Ossenkoppele G.J., Heimans J.J. Long term effects of vincristine on the peripheral nervous system. J Neurooncol. 15:1993;23-27.
54. Postma T.J., Vermorken J.B., Liefting A.J.M., Pinedo H.M., Heimans J.J. Paclitaxel-induced neuropathy. Ann Oncol. 6:1995;489-494.
55. Pradat P.-F., Finiels F., Kennel P., Naimi S., Orsini C., DeLaere P., Revah F., Mallet J. Partial prevention of cisplatin-induced neuropathy by electroporation-mediated nonviral gene transfer. Hum Gene Ther. 12:2001;367-375.
56. Quasthoff S., Hartung H.-P. Chemotherapy-induced peripheral neuropathy. J Neurol. 249:2002;9-17.
57. Rowinsky E.K., Chaudry V., Cornblath D.R., Donehower R.C. Neurotoxicity of taxol. J Natl Cancer Inst Monogr. 15:1993;107-115.
58. Ruff R.M., Parker S.B. Gender and age-specific changes in motor speed and eye-hand coordination in adults: normative values for finger tapping and grooved pegboard tests. Percept Mot Skills. 76:1993;1219-1230.
59. Sandler S.G., Tobin W., Henderson E.S. Vincristine-induced neuropathy. A clinical study of fifty leukemic patients. Neurology. 19:1969;367-374.
60. Schiff P.B., Horwitz S.B. Taxol stabilizes microtubules in muse fibroblast cells. Proc Natl Acad Sci USA. 77:1980;1561-1565.
61. Schmidt S.L., Oliveira R.M., Rocha F.R., Abreu-Villaça Y. Influence of handedness and gender on the grooved pegboard test. Brain Cogn. 44:2000;445-454.
62. Simone D.A., Kajander K.C. Responses of cutaneous a-fiber nociceptors to noxious cold. 1997;The American Physiological Society, Bethesda, MD.
63. Simone D.A., Kajander K.C. Excitation of rat cutaneous nociceptors by noxious cold. Neurosci Lett. 213:1998;53-56.
64. Tanner K.D., Levine J.D., Topp K.S. Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J Comp Neurol. 395:1998;481-492.
65. Tanner K.D., Reichling D.B., Levine J.D. Nociceptor hyper-responsiveness during vincristine-induced painful peripheral neuropathy in the rat. J Neurosci. 18:1998;6480-6491.
66. Theiss C., Meller K. Taxol impairs anterograde axonal transport of microinjected horseradish peroxidase in dorsal root ganglia neurons in vitro. Cell Tissue Res. 299:2000;213-224.
67. Thompson S.W., Davis L.E., Kornfeld M., Hilgers R.D., Standefer J.C. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer. 54:1984;1269-1275.
68. Topp K.S., Tanner K.D., Levine J.D. Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat. J Comp Neurol. 424:2000;563-576.
69. Torebjork H.E. Afferent C units responding to mechanical, thermal and chemical stimuli in human non-glabrous skin. Acta Physiol Scand. 92:1974;374-390.
70. Wahren L.K., Torebjörk E., Jörum E. Central suppression of cold-induced C fibre pain by myelinated fibre input. Pain. 38:1989;313-319.
71. Weiden P.L., Wright S.E. Vincristine neurotoxicity. N Engl J Med. 286:1972;1369-1370.
72. Weng H.-R., Cordella J.V., Dougherty P.M. Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia. Pain. 103:2002;131-138.
73. Yarnitsky D., Ochoa J.L. Warm and cold specific somatosensory systems. Brain. 114:1991;1819-1826.
74. Younger D.S., Mayer S.A., Weimer L.H., Alderson L.M., Seplowitz A.H., Lovelace R.E. Colchicine-induced myopathy and neuropathy. Neurology. 41:1991;943-944.
75. Ziegler E.A., Magerl W., Meyer R.A., Treede R.D. Secondary hyperalgesia to punctate mechanical stimuli. Central sensitization to A-fibre nociceptor input. Brain. 122:(Pt 12):1999;2245-2257.